香豆素-3-甲酰苄胺的合成及晶体结构

以香豆素-3-甲酸乙酯(1)为前驱体,与苄胺发生酯的胺解反应,合成了酰胺型香豆素衍生物香豆素-3-甲酰苄胺,通过红外光谱、核磁共振光谱以及X-射线单晶衍射对其进行了结构表征。晶体结构结果表明,每个晶胞中包含2个香豆素-3-甲酰苄胺分子,两个分子之间通过C5-H5···O3和C7-H7···O3氢键相互作用形成环状二聚体,再进一步通过C2-H2···O1氢键作用组装成一维链状结构。     

α-(1-苯基-3-三氟甲基-5-氯呲唑-4-甲酰氧基)-α-芳甲基膦酸酯的合成、晶体结构与生物活性

通过1-苯基-3-三氟甲基-5-氯吡唑-4- 甲酰氯(4)与α-羟基芳甲基膦酸酯(6)的缩合反应,合成了14种标题化合物7a～7n.所有化合物的结构均经1H NMR,1R和元素分析进行了表征,并且采用X射线单晶衍射分析方法进一步测定了化合物7j的结构.初步的生物活性测试表明,部分标题化合物具有一定的杀菌和除草活性.     

以(+)-樟脑缩苄胺作中间体对映选择合成(R)-α-取代苄胺

本文报道以(+)-樟脑作手性助剂, 苄胺为原料, 二者缩合制得的酮亚胺作中间体3,不对称合成(R)-α-取代苄胺(7)的一条有效新途径。化合物3用丁基锂去质子化提供的锂衍生物4和卤代烷反应, 以较高立体选择性产生烷基化产物6, 化合物6用醋酸羟胺转氨反应后, 获得了光学产率为4.6-90%的(R)-α-取代苄胺(7), 以肟的形式回收(+)-樟脑。     

1-取代哌啶-4-酮芳甲酰腙的合成及其抗白血病活性

以取代苄胺或伯胺为原料,依次经过Michael加成、Dieckmann缩合、水解脱羧、酰腙化反应合成了10个未见文献报道的1-取代哌啶-4-酮芳甲酰腙9a～9j,化合物结构经1H NMR,IR,MS和元素分析确证.初步的生物活性测试表明,部分化合物能有效抑制白血病K562细胞的增殖,具有潜在的抗白血病活性.     

2-氟-6-氟苯甲酰基嘧啶基硫脲的合成及生物活性研究

合成了7个未见文献报道的2-氟-6-氯苯甲酰基硫脲，其结构经元素分析、~1H NMR和IR确证。初步活性测试结果表明：部分化合物具有较好的除草活性。     

无溶剂法合成4,6,10,12,16,18,22,24-八羟基-2,8,14,20-四-{(联三-(3-苯基-2,4,8,10-四氧杂螺[5.5]十一烷基))-(4-(2-(4,6,10,12,16,18,22,24-八羟基)杯芳基)苯基)}杯芳烃螺环树形大分子化合物

以对苯二甲醛、丙二腈为原料, 合成对苯二甲醛单缩醛, 再与季戊四醇反应得到了2,4,8,10-四氧杂-2,9-二(4-二氰基乙烯基苯基)螺[5.5]十一烷, 经水解, 与丙二腈反应, 制备了中间体2,4,8,10-四氧杂-2-(4-二氰基乙烯基苯基)-9-(4-甲酰基苯基)螺[5.5]十一烷(3). 用乙酸酐保护的对苯二甲醛单缩醛与间苯二酚反应, 制备了杯芳烯中间体(6). 将化合物6与过量的化合物3反应, 得到中间体7, 经水解后与过量的化合物6反应, 得到了4,6,10,12,16,18,22,24-八羟基-2,8,14,20-四-{(联三-(3-苯基-2,4,8,10-四氧杂螺[5.5]十一烷基))-(4-(2-(4,6,10,12,16,18,22,24-八羟基)杯芳基)苯基)}杯芳烃螺环树形大分子化合物(9). 总收率为12.7%. 产物结构用IR, 1H NMR, 13C NMR, MS 和元素分析进行了表征, 对影响反应的因素进行了讨论.     

5-嘧啶基-1,2,4-噁二唑衍生物的合成及生物活性研究

通过嘧啶甲酰氯与取代的苄胺肟反应得到一系列结构新颖的5-嘧啶基-1,2,4-噁二唑类化合物,并对其结构进行了表征,培养并测定了化合物5a的晶体结构;将目标化合物晶体结构对接到靶酶酵母乙酰辅酶A羧化酶(ACCase)的活性位点,发现目标化合物与复合物晶体中的禾草灵分子的构象及结合模式相似;初步生物活性测试表明部分化合物具有较好的除草活性.     

2-芳基-5-(4-硝基苯甲酰氨基)-1,3,4-噻二唑的合成

以芳甲酰肼和对硝基苯甲酰氯为主要原料, 合成出了10个酰氨基硫脲化合物5a～5j, 其中有6个(5d, 5f～5j)为新化合物. 在无需任何酸性催化剂条件下, 将制得的酰氨基硫脲在DMF中加热回流直接脱水关环合成出了9个2-芳基-5-(4-硝基苯甲酰氨基)-1,3,4-噻二唑化合物6a～6i, 其中7个(6b～6d, 6f～6i)为新化合物. 利用IR和1H NMR证明了化合物5存在两种异构体. 目标产物的结构通过IR, 1H NMR和元素分析进行了表征.     

2-芳甲酰氨基硫羰基-3-异噻唑酮及4-氰基-5-甲硫基-2-芳甲酰氨基硫羰基-3-异噻唑酮的合成与生物活性

通过3-羟基异噻唑(4)和4-氰基-5-甲硫基-3-羟基异噻唑(5)分别与芳酰基异硫氰酸酯(3)反应,合成标题化合物2-芳甲酰氨基硫羰基-3-异噻唑酮(6a_6f)和4-氰基-5-甲硫基-2-芳甲酰氨基硫羰基-3-异噻唑酮(7a_7e),对此反应及产物的结构特点进行了探讨.     

6-氯-2-氯甲基-3-喹啉甲酸乙酯与胺的反应研究

以6-氯-2-氯甲基-3-喹啉甲酸乙酯(1)为底物,在溶剂无水乙醇中与胺及胺的衍生物2a-p反应,以较好的收率(64.8-77.7%)得到7-氯-2,3-二氢-1H-吡咯并[3,4-b]喹啉-1-酮衍生物,其中与芳胺反应生成N-芳基取代的化合物3a-i,与氨水、甲胺、乙胺和苄胺反应生成N-烷基取代的化合物3j-m,与乙二胺、丙二胺及丁二胺反应生成具有对称结构的化合物3n-p.该反应具有操作简便、条件温和等特点.所有化合物均为新化合物,其结构经IR、1H NMR、13C NMR、MS和HRMS得以证实.     

Synthesis of new visnagen and khellin furochromone pyrimidine derivatives and their anti-inflammatory and analgesic activity

6-[(4-Methoxy/4,9-dimethoxy)-7-methylfurochromen-5-ylideneamino]-2-thioxo-2,3-dihydropyrimidin-4-ones 1a,b were prepared by reaction of 6-amino-2-thiouracil with visnagen or khellin, respectively. Reaction of 1a,b with methyl iodide afforded furochromenylideneaminomethylsulfanylpyrimidin-4-ones 2a,b. Compounds 2a,b were reacted with secondary aliphatic amines to give the corresponding furochromen-ylideneamino-2-substituted pyrimidin-4-ones 3a-d. Reaction of 3a-d with phosphorus oxychloride yielded 6-chlorofurochromenylidenepyrimidinamines 4a-d, which were reacted with secondary amines to afford furochromenylideneamino-2,6-disubstituted pyrimidin-4-ones 5a-d. In addition, reaction of 5a-d with 3-chloropentane-2,4-dione gave 3-chloro-furochromenylpyrimidopyrimidines 6a-d. The latter were reacted with piperazine and morpholine to give 1-(furochromenyl)-pyrimidopyrimidine-3,6,8-triylpiperazines or -3,6,8-triylmorpholines 7a-d. The chemical structures of the newly synthesized compound ware characterized by IR, 1H-NMR, 13C-NMR and mass spectral analysis. These compounds were also screened for their analgesic and anti-inflammatory activities. Some of them, particularly 3-7, exhibited promising activities.     

2－甲基－3－芳基－7－（5，5－二甲基－3－酮－1－环己烯－1－基）甲酸酯－4（3H）－喹唑啉酮的合成

以2－氨基对苯二甲酸（1）为起始原料，与乙酸酐缩合生成7－羧基乙酰苯邻 甲内酰胺（2）；2和芳胺缩合产生7－羧基－2－甲基－3－芳基－4（3H）－喹唑啉 酮（3）；3和N，N－双环己基碳双亚胺（DCC）加成得到中间体4，4在4－二甲氨基 吡啶（DMAP）催化下和5，5－二甲基－1，3－环己二酮（5）缩合得到目标产物2－ 甲基－3－芳基－7－（5，5－二甲基－3－酮－1－环己烯－1－基）甲酸酯－4（ 3H）－喹唑啉酮（6）。所得15个新型化合物的结构均经^1H NMR、元素分析确证， 部分化合物经IC／MSD确证。     

全氟和多氟烷基磺酸的研究 VIII: N-(3'-三氯硅基丙基)-3-氧杂全氟烷基磺酰胺及基衍生物的合成

3-OXaperfluoroalkanesulfonyl fluoride (1) reacted with allylamine to give the corresponding N-allylsulfonamide 2 which on treatment with sodium methoxide and methyl iodide affrded N-methyl-N-allyl-3 -oxaperfluoroalkanesulfonamide 3. 2 and 3 were converted to the corresponding substituted trichlorosilanes 4 and 5 respectively on treatment with trichlorosilane in the presence of chloroplatinic acid. Compounds 5 reacted with methanol and pyridine to give the corresponding trimethoxysilane 6. The elemental analysis, IR, ^1H NMR and 19F NMR data of these new compounds were recorded in Table 1-4. The compounds 4, 5 can be used for the treatment of glass surface to render it water-proof and solvent-proof.     

Synthesis of Polymer-Bonded Quaternary Ammonium Type Metal Porphyrins

Synthetic metalloporphyrin are efficient models of the cytochrome P-450 family ofmono-oxygen enzymes and have been largely used as catalysts in oxidation of alkanesand epoxidation of alkenesl. Polymer-bonded metalloporphyrin reveal many advantageson the catalytic reaction, where the catalysts can be easily separated from the products,recovered, and reused2. Quaternary ammonium salts as phase transfer catalysts werewide used in aqueous-organic two-phase conditions. Unfortunately, most porphyrin…     

4-氯-1,7-二羟基二氢化茚的合成及意外醚化反应的研究

以对氯苯酚(8)为原料、三乙胺作缚酸剂，与丙烯酰氯反应生成对氯苯酚丙烯 酸酯(7)，7与A1Ck共热155℃，首先发生Fries重排，然后关环得到4-氯-7-羟基二 氢化茚-1-酮(6)，再用NaBHl／CH_3OH或LiAlH_4／THF还原6的羰基得到4-氯-1，7- 二羟基二氢化茚(5)．条件控制不当易产生两个意外的醚化产物4-氯-1-甲氧基-7- 羟基二氢化茚(9)和自身醚化产物10，9的结构经x射线单晶衍射分析确证，并提出 生成10的可能机理为5的醇羟基极易通过分子内催化形成碳正离子、进而与另一分 子5形成自身醚化产物10．因此，还原反应完成后的后处理应避免长时间放置和加 热，以减少醚化产物的生成．化合物5，9，10均为未见文献报道的新化合物．     

Solvent‐free Synthesis of 2,6‐Dihydroxy‐9H‐purin and Pteridine Derivatives

5,6‐Diaminopyrimidin‐2,4‐diol 1 was reacted with 1,4‐d ‐gluconolactone 2 , 6‐chloro‐4‐cyclopropyl‐7‐floro‐1,4‐dihydro‐1‐oxonaphthalen‐2‐carboxilic acid 4 , (3S)‐9,10‐difloro‐3,7‐dihydro‐3‐methyl‐7‐oxo‐2H‐[1,4]oxazino[2,3,4‐ij]quinolin‐6‐carboxylic acid 6 , and dimethylacetylendicarboxylate to afford 1‐(2,6‐dihydroxy‐9H‐purin‐8‐yl)‐sorbitol 3 , 7‐chloro‐1‐cyclopropyl‐6‐flouro‐3‐(2,6‐dihydroxy‐9H‐purin‐8‐yl)quinoline‐4(1H)‐one 5 , 9,10‐difluoro‐2,3‐dihydro‐6‐(2,6‐dihydroxy‐9H‐purin‐8‐yl)‐3‐methyl‐[1,4]oxazine[2,3,4‐ij]quinoline‐7‐one 7 , and (2,4‐dihydroxy‐6‐oxo‐5,8‐dihydro‐6H‐pteridine‐7‐yiliden)‐acetic acid methyl ester 9 , respectively. The synthesized compounds characterized by IR, ¹H‐NMR, ¹³C‐NMR, GC‐mass, and elemental analysis.     

Study on the Chemical Constituent from the Seed of Litchi chinensis Sonn.

Seed of Litchi chinensis Sonn. is a traditional Chinese medicine, having curative effects on gastric disease, diabetes,and relieving pain.[1] Two new compounds 4-O-p-coumaroylquinic acid butyl ester (1) and 3-O-p-coumaroylquinic acid butyl ester (2), along with five known compounds: 5-O-p-coumaroylquinic acid butyl ester (3),[2] 3-O-p-coumaroylquinic acid methyl ester (4),[3] n-butyl-1-β-D-fructopyranoside (5),[4] D-1-O-methylmyo-inositol (6)[5] and 1H-imidazole-2,3-dihydro-2-oxo-4-carboxylic acid methyl ester (7)[5] were isolated and purified from the ethanol extracts of the seed of L.chinensis Sonn. Their structures, shown in Figure 1, were elucidated by ESI-MS, 1H NMR and 13C NMR, including 2DNMR spectroscopy.     

Synthesis and Reaction of Novel Spiro Pyrimidine Derivatives

2‐Mercapto‐6‐[(pyridin‐4‐ylmethylene)‐amino]‐3H‐pyrimidin‐4‐one 1 was synthesized from Schiff base reaction of 6‐amino‐2‐thiouracil with isonicotinaldehyde. The reaction of 1 with hydrazonyl chloride 2a , 2b , 2c , 2d afforded the novel pyrimidin‐4‐one 3a , 3b , 3c , 3d . Compounds 3a , 3b , 3c , 3d reacted with methyl iodide to give 4a , 4b , 4c , 4d . Subsequently, reaction of 4a , 4b , 4c , 4d with triethylamine as a catalyst in dry chloroform yielded tetraaza‐spiro[4.5]deca‐2, 8‐dien‐7‐one 5a , 5b , 5c , 5d . In addition, reaction of 1 with acrylonitrile gave pyrimidin‐propionitrile 6 . The cyclization of 6 by reacting with sodium ethoxide to give pyrimido [2, 1‐b] [1,3] thiazin‐6‐one 7 . The refluxing of 1 with bromine in acetic acid yielded 2‐bromo‐pyrimidin‐4‐one 8 . The latter compound 8 reacted with sodium azide gave tetrazolo‐pyrimidine 10 . The chemical structures of the newly synthesized compounds were characterized by IR, ¹H NMR, ¹³C NMR, and mass spectral analysis.     

新型胍基葡萄糖苷的合成及生物活性

将2,3,4,6-四-O-乙酰基-β-D-吡喃葡萄糖基异硫氰酸酯(1)与2-氨基-4/6-取代-苯并噻唑(2a~2e)反应, 生成糖基硫脲衍生物(3a~3e), 再在伯胺存在下经氯化汞脱硫, 得到一系列新的多乙酰基胍基糖苷类化合物(4a~4d, 5a~5d, 6a~6d, 7a~7d), 糖基的保护基团在甲醇钠/甲醇条件下脱除. 所有新化合物的结构均经IR, 1H NMR, MS谱和元素分析证实, 所得产物均为β-构型. 生物活性测试结果表明, 化合物4c, 6c, 8b, 8c等对HIV-1蛋白酶表现出了较高的抑制活性; 化合物7c具有抗流感乙型病毒活性; 化合物5e, 7c, 7d等对血管紧张素转化酶具有抑制活性.     

Bioactive Components from the Mycelium of Antrodia Salmonea

Three new compounds, 2,4‐dimethoxy‐6‐methylbenzene‐1,3‐diol ( 1 ), salmoquinone ( 2 ), and 3‐(4‐hydroxyphenyl)‐4‐isobutyl‐1H‐pyrrole‐2,5‐dione ( 3 ), together with six known compounds, 2‐methoxy‐6‐methyl‐p‐benzoquinone ( 4 ), 2,3‐dimethoxy‐5‐methyl‐p‐benzoquinone ( 5 ), 2‐hydroxy‐5‐methoxy‐3‐methyl‐p‐benzoquinone ( 6 ), eburcoic acid ( 7 ), fomefficinic acid C ( 8 ), and a pyrroledione ( 9 ), were isolated from the mycelium of Antrodia salmonea. The structures of these compounds were elucidated by spectrometric analyses including IR, NMR, and MS. Among these compounds, 4 and 5 exhibited cytotoxicity against KB, HepG2, and H2058 cell lines.